# Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

> **NCT00249769** · PHASE3 · COMPLETED · sponsor: **PATH** · enrollment: 600 (actual)

## Conditions studied

- Encephalitis, Japanese B

## Interventions

- **BIOLOGICAL:** Live Japanese encephalitis vaccine SA 14-14-2 (LJEV)
- **BIOLOGICAL:** Measles Vaccine (MV)

## Key facts

- **NCT ID:** NCT00249769
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-21
- **Primary completion:** 2006-05-30
- **Final completion:** 2006-05-30
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249769, "Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00249769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*